Condition
Acquired Von Willebrand Disease
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Unknown2
Recruiting1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07358013Recruiting
Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
NCT04281771Not ApplicableActive Not Recruiting
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
NCT05846854Not ApplicableUnknown
Decreasing Hemorrhage Risk in Children With Alagille Syndrome
NCT03613584Phase 2UnknownPrimary
Von Willebrand Factor Concentrate During ECMO Support
Showing all 4 trials